Genomic landscape of meningiomas

Brain Pathology

Volumn 20, Issue 4, 2010, Pages 751-762

  Lee, Yohan ^a   Liu, Jason ^a   Patel, Shilpa ^a   Cloughesy, Timothy ^a   Lai, Albert ^a   Farooqi, Haumith ^a   Seligson, David ^a   Dong, Jun ^a   Liau, Linda ^a   Becker, Donald ^a   Mischel, Paul ^a   Shams, Soheil ^b   Nelson, Stanley ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BioDiscovery Inc   (United States)

Author keywords

Affymetrix; BioDiscovery; Brain tumor; DChip; GeneChip Human Mapping 100K Array; Genomics; Human Genome U133 Plus 2.0 Array; Meningioma; Microarray; Nexus; SNP

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CELL PROLIFERATION; CHROMOSOME 14Q; CHROMOSOME 22Q; CHROMOSOME 6Q; CHROMOSOME LOSS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE NUMBER; GENETIC ANALYSIS; GENOMICS; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; NEUROSURGERY; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; CHROMOSOME ABERRATION; DNA MICROARRAY; GENETICS; HUMAN GENOME; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION; GENOME, HUMAN; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77953182050     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00356.x     Document Type: Article

References (37)

1. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101 : 210 218.
2. Ammerlaan A, Houben M, Tijssen CC, Wesseling P, Hulsebos TJ (2008) Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation. Childs Nerv Syst 24 : 855 857.
3. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 : 185 193.
4. Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P et al (2007) Molecular signatures define two main classes of meningiomas. Mol Cancer 6 : 64.
5. Chamberlain MC, Tsao-Wei DD, Groshen S (2004) Temozolomide for treatment-resistant recurrent meningioma. Neurology 62 : 1210 1212.
6. Day A, Carlson MR, Dong J, O'Connor BD, Nelson SF (2007) Celsius: a community resource for Affymetrix microarray data. Genome Biol 8 : R112.
7. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM et al (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64 : 6503 6510.
8. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5 : R80.
9. Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K et al (2000) Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 9 : 1495 1500.
10. Hehir-Kwa JY, Egmont-Petersen M, Janssen IM, Smeets D, van Kessel AG, Veltman JA (2007) Genome-wide copy number profiling on high-density bacterial artificial chromosomes, single-nucleotide polymorphisms, and oligonucleotide microarrays: a platform comparison based on statistical power analysis. DNA Res 14 : 1 11.
11. Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T et al (2004) Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep 12 : 1087 1092.
12. Lamszus K, Kluwe L, Matschke J, Meissner H, Laas R, Westphal M (1999) Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110 : 103 110.
13. Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT, Jr., Omalu B (2004) Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 55 : 1163 1173.
14. Lekanne Deprez RH, Riegman PH, Groen NA, Warringa UL, van Biezen NA, Molijn AC et al (1995) Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10 : 1521 1528.
15. Lin KR, Lee SF, Hung CM, Li CL, Yang-Yen HF, Yen JJ (2007) Survival factor withdrawal-induced apoptosis of TF-1 cells involves a TRB2-Mcl-1 axis-dependent pathway. J Biol Chem 282 : 21962 21972.
16. Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH et al (2004) Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 67 : 221 226.
17. Lusis E, Gutmann DH (2004) Meningioma: an update. Curr Opin Neurol 17 : 687 692.
18. Mailand N, Lukas C, Kaiser BK, Jackson PK, Bartek J, Lukas J (2002) Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation. Nat Cell Biol 4 : 317 322.
19. McMullen KP, Stieber VW (2004) Meningioma: current treatment options and future directions. Curr Treat Options Oncol 5 : 499 450.
20. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G et al (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22 : 2361 2373. (Pubitemid 36566791)
21. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C et al (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63 : 1602 1607.
22. Ozaki S, Nishizaki T, Ito H, Sasaki K (1999) Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. J Neurooncol 41 : 167 174.
23. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70 : 183 202.
24. Peyrard M, Pan HQ, Kedra D, Fransson I, Swahn S, Hartman K et al (1996) Structure of the promoter and genomic organization of the human beta′-adaptin gene (BAM22) from chromosome 22q12. Genomics 36 : 112 117.
25. Peyrard M, Seroussi E, Sandberg-Nordqvist AC, Xie YG, Han FY, Fransson I et al (1999) The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci U S A 96 : 598 603.
26. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9 : 157 173.
27. Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19 : E9.
28. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK et al (2005) Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65 : 4051 4058.
29. Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5 : 1045 1054.
30. Schmitz U, Mueller W, Weber M, Sévenet N, Delattre O, von Deimling A (2001) INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 84 : 199 201.
31. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF et al (2003) Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22 : 4918 4923. (Pubitemid 36981282)
32. Slater HR, Bailey DK, Ren H, Cao M, Bell K, Nasioulas S et al (2005) High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am J Hum Genet 77 : 709 726.
33. Sulman EP, White PS, Brodeur GM (2004) Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene 23 : 1014 1020.
34. Uekita T, Gotoh I, Kinoshita T, Itoh Y, Sato H, Shiomi T et al (2004) Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors. J Biol Chem 279 : 12734 12743.
35. Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW (2004) Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma. Neurosurgery 54 : 55 63 discussion 4.
36. Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114 : 249 256.
37. Yue H, Jiang HY (2005) Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study. World J Gastroenterol 11 : 5057 5060.